About
Predicting Drug Success in Clinical Trials
OMEC.AI's mission is to help pharmaceutical companies have better chances in clinical trials by making better data-driven decisions in the pre-clinical process. The company provides an automated, data-focused solution that can produce a reliable assessment of the clinical trial-readiness of a proposed drug. OMEC.AI was established with funding and support from AION Labs, a collaboration between pharmaceutical giants Pfizer, AstraZeneca, Merck, and Teva Pharmaceuticals, together with Amazon's AWS and the Israel Biotech Fund.
Identity
| Name | OMEC.AI |
|---|---|
| Slug | omec-ai |
| Type / kind | startup |
| Crunchbase ID | omec-ai |
| Source _id | kGKdbEU2EptEitDveFkkLKwRdmlXO3EdovDr2iysiXFq41xb2LTOYu |
Status
| Status | inactive |
|---|---|
| Status reason | Non Active, Jul 2023 ceased to operate |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ city | Rehovot |
| HQ address | Rehovot, Israel |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Artificial Intelligence
Target customers
Healthcare & Life SciencesHealthcareLaboratoriesLife SciencesPharmaceuticals
Business models
B2C
Tags
biopharmaceuticalartificial-intelligenceclinical-trialsdrug-developmentdrug-discovery
Funding
| Total raised | $2.0M |
|---|---|
| Current stage | Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}